Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 30%
Hold 30%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is well-positioned to take advantage of these opportunities and continue to grow its market share. The establishment of a new Ambulatory Network Group and a new Chief Operating Officer for the company's Ambulatory Operations demonstrates a commitment to expanding its outpatient network, which is expected to drive further growth. The company's strong financial performance, with an enterprise multiple of ~9.2x, reflects its leading position in primary urban markets and a robust patient protection framework that includes a charity care program and policies to help patients with out-of-pocket costs.

Bears say

HCA Healthcare is facing multiple challenges due to the evolving healthcare landscape, with increasing competition among hospitals and an uncertain regulatory environment for government healthcare programs and managed care payors. The company is also facing tight labor markets, which may impact productivity and margins, particularly in urban areas. Additionally, there is uncertainty surrounding the impact of metal-tier mix shifts and higher patient cost sharing on the company's financials. These factors may lead to cost headwinds and could result in a potential downside for the stock.

HCA Healthcare (HCA) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 20 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $471.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $471.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.